Enorama Pharma AB (publ) (STO:ERMA)
1.240
+0.848 (216.33%)
Aug 14, 2026, 5:29 PM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 92.49 million as of August 14, 2026. Its market cap has decreased by -52.66% in one year.
Market Cap
92.49M
Enterprise Value
74.73M
Revenue
2.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.24
ChartMarket Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has increased from 35.83M to 92.49M, an increase of 158.16%. That is a compound annual growth rate of 9.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 92.49M | -35.08% |
| Dec 30, 2025 | 142.46M | -29.89% |
| Dec 30, 2024 | 203.19M | 77.51% |
| Dec 29, 2023 | 114.47M | 308.04% |
| Dec 30, 2022 | 28.05M | -83.60% |
| Dec 30, 2021 | 171.01M | -12.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 868.50M |
| EQL Pharma AB | 742.67M |
| Dicot Pharma AB | 702.76M |
| Cinclus Pharma Holding AB | 550.08M |
| Orexo AB | 546.87M |
| Moberg Pharma AB | 514.19M |
| Enzymatica AB | 497.61M |
| Klaria Pharma Holding AB (publ.) | 226.30M |